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Introduction: The aim of this studywas to assess the applicability of fractional flow reservemeasurement (FFR) in
below-the-knee (BTK) arteries and to evaluate its correlation with non-invasive functional parameters before
and after angioplasty.
Methods:We enrolled 39 patients with severe BTK arterial lesions. Inclusion criteria were critical limb ischemia
(Rutherford 4–6) and angiographically proven arterial stenosis of the distal lower limb (percent diameter steno-
sis ≥70%). Exclusion criteria were chronic total occlusion, diabetic foot syndrome and non-viable distal lower
limb. The transstenotic distal/proximal pressure ratio was measured under resting (Pd/Pa) and hyperemic
(FFR) conditions induced by 40 mg intra-arterial Papaverin and was compared with quantitative angiography-,
laser Doppler- and duplex ultrasound-derived measurements before and after percutaneous angioplasty (PTA).
Results: Comparing measurements before and after PTA, we found significant improvements in the resting Pd/Pa
values (0.79 [0.67–0.90] vs 0.90 [0.85–0.97]; p b 0.001) and FFR values (0.60 ± 0.19 vs 0.76 ± 0.15; p b 0.001),
respectively. At baseline, Pd/Pa ratio and FFR were significantly albeit weakly correlated with % area stenosis
(r:−0.31, p = 0.05 and r:−0.31, p = 0.05, respectively). After PTA, neither Pd/Pa nor FFR remained correlated
with % area stenosis. Similarly, prior PTA, Pd/Pa ratio and FFR were significantly correlated with TcO2% and per-
fusion unit change (r:0.48, p b 0.01 and r:0.34, p b 0.05, respectively), but after intervention, these significant cor-
relations vanished. Pd/Pa and FFR values did not show correlation with duplex ultrasound-derived
measurements. At 1 year, major adverse events (MAEs) and major adverse cardiovascular and cerebrovascular
(MACCEs) were observed in 7 (17.9%) and in 9 (23.1%) patients, respectively.
Conclusion: CLI due to severe BTK arterial diseasewas associatedwith several impediments of baseline pressuremea-
surements which were significantly improved after successful PTA and stenting. Significant relationships between
pressure data and functional and imaging parameters existed prior intervention but vanished after. Further studies
are required to determine the clinical value of pre- and post-PTA pressure measurements in BTK arterial disease.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).CLI, critical limb ischemia; DPU,
FFRperiph, Peripheral fractional
eter; PTA, percutaneous translu-
ange in DPU; %TcO2, Percentage
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eart and Vascular Center, Buda-
. This is an open access article under1. Introduction
Translesional pressure measurement with pressure sensor wires
was first validated in peripheral arteries [1], followed by intracoronary
[2] and renal arteries [3]. Translesional pressure measurement was
primarily focused on systolic gradient and remained the gold standard
in peripheral arteries for years. In coronary and renal arteries, a novel
pressure-derived metric, the fractional flow reserve (FFR), was intro-
duced and was found to be more closely correlated with coronary
physiology [2–4]. However, the application of FFR measurement in the
peripheral circulation has not been thoroughly investigated [5–10].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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traditional functional diagnostic approach to peripheral vascular disease
is still non-invasive. As described previously, critical limb ischemia (CLI)
is associatedwith an ankle systolic pressure ≤ 50mmHg or a toe systolic
pressure of 30 mmHg or less [11]. Generally, a toe-brachial pressure
index (TBPI) of b0.75 is predictive of the presence of hemodynamically
significant peripheral artery disease [12]. Numerous studies have
shown that a transcutaneous O2 (TcO2) pressure b to 30mmHg is con-
sistent with poor wound healing [13].
The aim of this study was to evaluate the usefulness of resting Pd/Pa
ratio and FFR measurements in the evaluation of peripheral artery dis-
ease and to evaluate its correlationwith non-invasive functionalmetrics
and with invasive morphological parameters before and after percuta-
neous transluminal angioplasty (PTA).2. Methods
2.1. Study population
We prospectively enrolled 39 consecutive patients with CLI and an-
giographically proven below-the-knee (BTK) stenosis. Inclusion criteria
were chronic critical limb ischemia (Rutherford 4–6) and angiographic-
ally proven significant lesion of the distal lower limb (Diameter stenosis
≥70%) [12]. Exclusion criteria included chronic total occlusion or other
morphologic appearance of thewound that makes FFR periphmeasure-
ment impossible or unacceptably risky, diabetic foot syndrome and
non-viable distal lower limb. Our Institutional Review Committee ap-
proved the study, and all patients provided written informed consent
prior to study inclusion.2.2. Angiographic findings
Peripheral angiography was performed following routine tech-
niques. Vessels and lesions were analyzed using a quantitative comput-
erized analysis (QCA) system (Innova 3100, General Electric Healthcare,
US) with contrast filled guiding catheter used for calibration. Minimum
lumen diameter (MLD), reference vessel diameter (RVD), percent area
stenosis (AS), percent diameter stenosis (DS) and lesion length (LL)
were measured before and after angioplasty.2.3. Pressure measurements, calculation of fractional flow reserve and
angioplasty
Pressure measurements were performed as follows: Following pe-
ripheral angiography, a 55 cm long 5F hydrophilic sheathwas advanced
into the popliteal artery through an anterograde common femoral
artery access. All patients received a bolus of intravenous unfractionated
heparin at doses determined according to bodyweight. After calibration
and equalization, the 0.014″ PressureWire™ Certus (St. JudeMedical, St.
Paul, MN, USA) was advanced as indicated through the sheath, distal to
the stenosis, in the most distal segment as possible. The following
measurements were taken at baseline and during maximal hyperemia,
which was induced by administration of 40 mg intraarterial papaverin
bolus: systolic pressure gradient (Dp), resting Pd/Pa ratio and peripher-
al FFR (FFR periph). Systolic peripheral wedge pressure (Pwedge) was
also measured during balloon dilatation.
After calibration, equalization and FFRmeasurementwe have done a
balloon angioplasty with a dedicated below-the-knee balloon and in
cases when the angiographic result showed significant recoil, or
dissection or the flow was slow, balloon expandable drug eluting stent
implantation was done. The revascularization strategy was direct
revascularization of the wound related artery, but in complex CTO
cases we have done an indirect revascularization with improving the
collateral flow from the major feeding artery.2.4. Laser Doppler examination
Laser Doppler examination was performed with a commercially
available laser Doppler system (PeriFlux system 500, Järfälla, Sweden).
Pre- and post-interventional segmental skin perfusion pressures in
Doppler perfusion units (DPU) and transcutaneous O2 pressure (tcO2)
were measured. DPU was measured at rest and after local heating
(Stress DPU), while TcO2 was measured at rest and after O2 inhalation.
The percent changes in DPU (%DPU change) and TcO2 (%TcO2 change)
were calculated before and 3 days after intervention.
2.5. Doppler ultrasound measurements
Peak systolic velocity (PSV) was measured in the distal portions of
the anterior and posterior tibial arteries, as appropriate.
2.6. Follow-up
The follow-up included a clinical examination, laser Doppler mea-
surements, andDoppler ultrasound prior to intervention, after interven-
tion, at 2 and 12 months after intervention. Follow-up included control
angiography at 12 months.
2.7. Endpoints and definitions
2.7.1. Clinical success
Primary clinical success was defined as an improvement in at least
one clinical category in the Rutherford-Becker classification at the
12-months follow-up [14]. Primary patency was defined as persistent
patency without clinical indication for re-intervention at the
12-month follow-up, including angioplasty, surgical procedures
performed on or at the margins of the treated lesion, and amputation.
Limb salvage was defined as prevention of any amputation. Major
amputation was defined as limb loss below or above the knee level,
while minor amputation was defined as an amputation at or distal
from the trans metatarsal level.
2.7.2. Technical success
Technical success was defined as PTA resulting in b30% residual
stenosiswith normal anterogradeflow. Accordingly, a suboptimal result
was defined as sluggish flow and/or residual stenosis of 30% to 50% after
repeated dilatation.
2.7.3. Major adverse events (MAE)
MAEs were a composite of death, repeat revascularization of the
target vessel by PTA or artery bypass graft operation or major amputa-
tion during the hospital stay and up to 12 months of follow-up.
2.7.4. Major adverse cardiac and cerebral events (MACCE)
MACCE were a composite of death, myocardial infarction, stroke,
coronary intervention or bypass operation.
2.7.5. Vascular complications
Major vascular complication was defined as diminished or lost
arterial pulse or the presence of any pseudoaneurysm or arteriovenous
fistula following the procedure or during clinical follow-up. Minor
vascular complicationwas defined as a hematoma of b5 cm in diameter
over the femoral puncture area that did not require further treatment.
Bleeding complication was defined as any bleeding with a fall in
hemoglobin level of N3 g/dl requiring a blood transfusion.
2.8. Statistical analysis
All statistical analyses were performed with Graph Pad Prism 6.
Continuous variables are presented as the mean ± standard deviation
(SD) or mean and interquartile ratio, as appropriate. Differences
Table 2
Angiographic and procedural data.
Quantitative measurements – Diameter stenosis (%)
Popliteal artery (P3 segment) 27 [13–30]
Anterior tibial artery 86 [78–94]
Peroneal artery 64 [54–75]
Tibiofibular artery 34 ± 32
Posterior tibial artery 87 [78–95]
Quantitative measurements and angiography at lesion site
Diameter stenosis (%) 65 ± 23
Area stenosis (%) 82 [76–89]
Reference vessel diameter (mm) 2.93 [2.6–3.25]
Minimum lumen diameter (mm) 1.0 ± 0.7
Lesion length (mm) 31 [23.4–37.8]
Severe calcification n (%) 9 (23.1)
Table 3
Procedural and Laser Doppler results.
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Mann-Whitney test, as appropriate. Correlations between variables
were analyzed using the Pearson or Spearman rank test, as appropriate.
Probability values lower than 0.05 were considered to be significant.
3. Results
3.1. Demographic and clinical data
The baseline demographic and clinical characteristics of the study
population are shown in Table 1. The clinical indications for the
procedures were rest pain in 12 patients (30.7%), arterial ulcer in 10
cases (25.6%) and gangrene in 17 patients (43.6%).
3.2. Angiographic and procedural data (see Table 2)
The interventions were completed with technical success in all
patients. Balloon angioplasty was performed in all cases, and additional
drug-eluting stent implantationwas indicated in 20 cases (51.3%). After
the procedure, % area stenosis improved from 82.35 [76.2–88.5] % to
42.9 ± 18.5% (p b 0.001), and the toe-to-brachial index increased
from 0.45 ± 0.21 to 0.54 ± 0.20 (p b 0.05) compared to prior PTA.
The clinical success rate at one year was 61.5%. Control angiography
was performed in 32/39 (82%) patients. Angiographic restenosis
(N50% diameter stenosis) was found in 13 patients (41%) at one year
angiographic follow up (4 in-stent restenosis and 9 restenosis after
balloon angioplasty.
3.3. Pressure wire measurements (see Table 3)
The mean systolic pressure gradient decreased from 45 [35.7–54.4]
mmHg before PTA to 20 [14.3–25.4] mmHg after intervention
(p b 0.001). Resting Pd/Pa improved significantly from 0.79 [0.67–0.9]
to 0.90 [0.85–0.97] (p b 0.001), and FFR periph significantly improved
from 0.60 ± 0.19 to 0.88 ± 0.12 (p b 0.01) (see Fig. 1). An 0.52 FFR
value (AUC: 0.724, sensitivity 88.9%, specificity 60%) had the best cut-
off value to predict area stenosis N70%. One year MAEs and MACCEs
were observed in 7 (17.9%) and in 9 (23.1%) patients. Neither the
laser, nor the pressure wire measurements were found significantly
different when direct or indirect revascularisation was done. The aver-
age systolic wedge pressure (Wp) during balloon inflation was 37.4
[28.6–46.2] mmHg, but in patients with at least one parallel chronic
total occlusion the systolic wedge pressure was significantly lower
(parallel CTO Wp: 32.47 ± 19.5 mmHg vs nonparallel CTO: 70.80 ±
41.2 mm Hg, p = 0.002). Significant difference was found between
FFR derived wedge pressures in patients with rest pain, crural ulcer
and pedal gangrene (46.3 ± 34.4 vs. 40.1 ± 26.6 vs. 28.5 ± 26.6Table 1
Demographic and clinical data.
Demographic and clinical data n (%)
Demographic data Age (years) 68 [65–71]
Male 30 (77)
BMI 29 ± 5
Hypertension 37 (95)
Smokers 29 (74)
Diabetes mellitus 26 (67)
Dyslipidaemia 35 (90)
Renal failure 12 (31)
Coronary artery disease 13 (33)
Atrial fibrillation 7 (18)
Indication Ischemic rest pain 12 (31)
Ulcer 10 (26)
Gangrena 17 (44)
Rutherford classification II4 14 (36)
III5 19 (49)
III6 6 (15)Hgmm, p b 0.05). FFR values pre 0.64 [0.31–0.98] vs 0.59 [0.53–0.66]
and post interventions 0.80 [0.6–1.0] vs 0.75 [0.69–0.81] were not
significantly different between the patients with parallel and
non-parallel CTO, respectively (Table 5).
3.4. Doppler ultrasound measurements (see Table 3)
3.4.1. Laser Doppler measurements (see Table 3)
Before and 3 days after the intervention, the rest DPU were 26
[20–31] and 27 [22–33] (p = ns), and the stress DPU were 141
[115–168] and 165± 86 (p= ns), respectively. Before and after the in-
tervention, the rest TcO2 values were 31± 18 and 30± 16 (p= ns) and
the TcO2 values after O2 inhalation were 116 [83–149] and 124 [90–159],
respectively (Fig. 2). Significant improvement in toe pressure (mmHg)
was observed from before to after the intervention (67 [57–77] vs. 79
[70–88] (p b 0.01)).
3.4.2. Correlations (Fig. 3, Table 4)
Distal pressure, Pd/Pa and FFR periph were significantly but weakly
correlated with %TcO2 change (r:−0.33,−0.36 and 0.34, respectively
(p b 0.05)). Furthermore, Distal pressure, Pd/Pa and FFR periph were
also significantly correlated with stress DPU (r:-0.44, 0.44, and 0.34,
respectively (p b 0.05)). Pd/Pa and FFRperiph were significantly
correlated with % area stenosis and % diameter stenosis (p b 0.05 for
all). Pressure wire measurement was not significantly correlated with
lesion length. Toe pressure was significantly correlatedwith distal pres-
sure, Pd/Pa and FFRperiph (r:−0.30, r:0.37 and 0.33 (p b 0.05),
respectively).Before intervention After intervention
Angiographic result
Diameter stenosis (%) 65 ± 23 26 ± 13 ***
Area stenosis (%) 82 ± [76–89] 43 ± 19 ***
Pressure wire measurements
Systolic pressure gradient (mm Hg) 45 [36–54] 20 [14–25] **
Pd/Pa 0.74 [0.67–0.81] 0.88 [0.84–0.92] **
FFRperiph 0.60 ± 0.19 0.77 ± 0.12 **
Wedge pressure (Hgmm) 37 [29–46] –
Laser Doppler measurements
rest DPU 26 [20–31] 67 [57–77]
stress DPU 141 [115–168] 165 ± 86
% DPU change 625 [435–816] 693 [515–872]
rest TcO2 31 ± 18 30 ± 16
TcO2 after O2 inhalation 116 [83–149] 124 [90–159]
%TcO2 change 243 ± 219 318 [154–482]
Toe pressure 27 [21–33] 79 [70–88]
Doppler US (dilated artery)
Distal anterior tibial artery (PSV- mm/s) 21 [21–33] 44 [34–54] **
Distal posterior tibial artery (PSV- mm/s) 26 [19–32] 29 [22–36]
Fig. 1. Pre- and post-interventional measurements. A: Pressure gradient. B: Pd/Pa ratio. C: FFRperiph.
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The rate of MAE during 12months of follow-upwas 23.7% (4 deaths,
2 major amputations, 4 re-interventions). The rate of MACCE up to
12months after intervention was 17.9% (4 deaths, 2 strokes, 3 coronary
interventions). FFR periph final value N0.66 (AUC: 0.624, sensitivity
77.8%, specificity 70%) had the best cut-off value to predict freedom
from 12 month MAEs. FFR derived wedge pressure was significantly
lower (7.5 ± 10.6 vs. 39 [30.5–47.9] Hgmm, p b 0.05) in patients
underwentmajor amputation at one year (n= 2), while other pressure
wire measurements were not statistically different.
4. Discussion
Severe peripheral artery disease is often the result ofmultisegment oc-
clusive disease in the arteries supplying the involved lower extremity.
While the aorta, iliac, femoral, and popliteal arteries can be involved,
there is a particularly high prevalence of tibioperoneal and pedal disease
in patients with CLI. The diagnosis of CLI is straightforward and is based
on vascular examination, including measurement of the ankle brachial
index (ABI) and TBPI and a number of imaging modalities, but all of
these examinations have limitations; thus, the gold standard for CLI diag-
nosis is still digital subtraction angiography (DSA). DSA clearly depicts theFig. 2. Pre- and post-interventional laser Doppler measurements.anatomy of the BTK segment, but does not provide information about the
severity of the functional impairment caused by the lesion or about leg
perfusion or viability. Foot perfusion can be analyzed with TBPI, TcPO2,
transcutaneous carbon dioxide and DPU. TcPO2 and TcPCO2 are
established indicators of local cutaneous perfusion, but measurements
of tcPO2 are often unreliable because they are influenced by many phys-
iological, methodological, and technical factors [15]. Of note, measure-
ments of DPU have no such limitations, and DPU is useful for predicting
wound healing in limbs in which neither ABP nor TBPI can be measured.
Despite the reliability of laser Doppler measurements, there is no func-
tional test available in the catheterization laboratory to obtain immediate
information about the functional significance of a singular BTK lesion or to
assess the results of angioplasty. Despite pressure improvements, we ob-
served non-significant improvements in the laser Doppler parameters at
3 days after intervention because the microcirculation was still damaged
at that time andmore timewas necessary for themicrocirculation abnor-
mality to resolve.
4.1. Direct pressure measurement in the peripheral circulation
The use of DSA in the BTK segment also has limitations because le-
sions in that location are very complex, a true reference segment hasA: Percentage change in DPU. B. Percentage change in TcO2.
Fig. 3. Correlation analysis curves of the correlations of resting Pd/Pa ratio (A) and FFRperiph (B) with area stenosis.
Table 4
Correlational data – baseline measurements.
DPU DPU at stress % Change in DPU TcO2 TcO2 at stress % Change in TcO2 Toe pressure
QCA
(AS)
0.09 −0.19 −0.19 0.03 −0.14 −0.12 −0.12
QCA
(DS)
0.16 −0.19 −0.28 −0.01 −0.20 −0.09 −0.20
QCA
(LL)
−0.03 −0.10 −0.03 0.17 0.16 0.17 0.08
DP 0.18 −0.33* −0.44** −0.14 −0.29 −0.44** −0.45**
Pd/Pa −0.14 0.36* 0.44** 0.09 0.35* 0.56*** 0.53***
FFRperiph −0.01 0.38* 0.34* 0.05 0.29 0.48** 0.49**
(r values, p b 0.05 *, p b 0.01 **)
Table 5
Pre and post-procedural pressure wire measurements in patients with and without the









- Dp 41 ± 42.9 42.2 [30.1–54.3] 49.4 [24.2–43.2]
- Pd/Pa 0.73 ± 0.32 0.77 [0.66–0.88] 0.71 [0.61–0.80]
- FFR Periph 0.64 ± 0.31 0.63 [0.52–0.73] 0.54 [0.46–0.62]






- Dp 21.6 ± 26.18 16.11 [10.3–21.9] 23.63
[13.36–33.89]
- Pd/Pa 0.86 ± 0.20 0.90 [0.85–0.94] 0.87 [0.80–0.93]
- FFR Periph 0.80 ± 0.17 0.81 [0.74–0.88] 0.70 [0.62–0.78]
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cannot properly predict the severity of the stenosis before and after
angioplasty. Direct pressure measurement may help resolve this
problem, but performance of this measurement is limited in the cathe-
terization laboratory. There is no consensus on the diagnostic
translesional pressure gradient criteria, but the most widely accepted
criteria utilize amean gradient of 15mmHg before or after vasodilators
and a peak systolic gradient of 10–20 mm Hg [9]. Garcia et al. reported
their experience with comparing catheter-derived pressure gradients
to pressure wire gradients in 20 lesions in 16 patients [5]. The
catheter-derived pressure gradients overestimated the pressure gradi-
ents compared to the pressure wire derived gradients. Lotfi et al. dem-
onstrated that the peripheral vascular bed responds to vasodilation
and found that a post-intervention pFFR of b0.95 predicted a more
rapid PSV over time, which is a reasonable surrogate for restenosis [6].
Recently, Hioki conducted a study on iliac stenosis and found a signifi-
cant linear correlation between post-exercise ABI and p-FFR at hyper-
emia, which was stronger than the correlation between post-exercise
ABI and peak-to-peak pressure gradient at hyperemia [8]. Banerjee S
et al. found that translesional gradient measured using a pressure wire
after administration of 100 μg of adenosine was strongly correlated
with rest ABI (r =−0.748); exercise ABI (r =−0.888), exercise dura-
tion (r = −0.711), and percent angiographic stenosis (r =−0.818)
(p b 0.01 for all) [10].
4.2. Drug used for hyperemia
Functional lesion severity can be assessed with the use of vasodilators
to simulate exercise and induce a more accurate physiologic gradient.Administration of nitroglycerin, adenosine or papaverin may be given in
an attempt to simulate stress-induced vasodilatation in the peripheral
circulation. In peripheral studieswith pFFRmeasurement, 200 μg of aden-
osinewas used to inducehyperemia and resulted in a goodhemodynamic
response [6–10]. Papaverin is a strong vasodilatator in the peripheral ar-
teries [16] that causes long-term vasodilation, and it is used for FFR mea-
surement in the coronary and renal vessels [3,17]. In our study, 40 mg
papaverin was used to initiate vasodilation in the BTK segment, and we
achieved a good hemodynamic response.
Potential clinical applications of pressure wire measurement in the
peripheral circulation include: first to assess stenosis severity of
Fig. 4. A 62-year-old male patient with rest pain. DSA shows critical tibioperoneal trunk stenosis (A). FFRperiph measurement before (B) and after stent implantation (C). Final
angiography shows no residual stenosis after stent implantation (D).
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dures, second to assess the immediate efficacy of the revascularization
procedure, which in turn can help predict long-term outcomes after
revascularization and assessment of individual contribution of each
stenosis in segments that contain long, diffuse disease. Fig. 4 presents
the findings of a representative case in which we used the pressure
wire in a significant BTK lesion before and after angioplasty.4.3. Further investigations
A dose response analysis comparing the abilities of different agents
and doses to inducemaximal hyperemia is necessary. It is also necessary
to clarify the true cut-off value of FFRperiph that indicates a significant
lesion in the BTK segment. In the coronary arteries, a FFR value of
b0.80 has been accepted to indicate a significant lesion in recent trials
[18]; however, in patients with CLI, many other factors can influence
FFRperiph, such as developed collaterals, microvascular disease
(infection, inflammation, and diabetic microangiopathy), and rheologi-
cal state. The systolic wedge pressure in the current study population
was 37.4 [28.6–46.2] mmHg, indicating that highly developed
collaterals are present in CLI patients. Pwedgewas negatively correlated
with Dp (r = 0.42, p = 0.007) and significantly positively correlated
with Pd/Pa and FFRperiph (r = 0.47, p = 0.002 and r = 0.43,
p = 0.005, respectively). Highly developed collaterals can cause false
high FFRperiph values; therefore, Pwedge must be taken into
consideration during FFR measurement. Pwedge was significantly
lower in patients underwent major amputation (7.5 ± 10.6 vs. 39
[30.5–47.9]Hgmm, p b 0.05),whichmeans that the lowwedge pressure
increase the risk of major amputation due to incomplete collateral
system of the lower limb.4.4. Study limitations
This was a proof of concept study investigating the feasibility of FFR
measurement in peripheral arteries; however, a small number of cases
were included in this study. Another limitation of this study is the lack
of a dose response analysis and the lack of a comparison of adenosine
to papaverin for the induction of hyperemia.5. Conclusion
Peripheral fractional flow reserve measurement is feasible and
correlates well with standard morphologic and indirect functional
parameters. Additional studies with larger patient series are necessary
to clarify the true value of fractional flow reserve for the guidance of
below-the-knee interventions.References
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